FDA Still Feels Transvaginal Mesh Products Too Risky After Final Postmarketing Study
Mesh exposure and erosion problems still make transvaginal mesh products not worth the potential risks, FDA determined
Mesh exposure and erosion problems still make transvaginal mesh products not worth the potential risks, FDA determined
Even though most cases were settled years ago, a recently filed transvaginal mesh lawsuit shows that many women may still be suffering from mesh failures.